Post-earnings recap
Reported
Thu, Aug 4, 2011
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's earnings report showed a small beat on EPS, but the stock fell by 4.32% in reaction. Investors may be concerned about the lack of revenue data and the absence of guidance, which could indicate uncertainty about future performance. The management's cautious tone may have contributed to the stock's decline as well.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.37 | N/A | +2.21% |
Management expressed cautious optimism about future growth despite current market challenges. They stressed the need for continued innovation and efficiency.
Management highlighted ongoing challenges in the market.
They emphasized the importance of innovation in their product lines.
There was a focus on maintaining operational efficiency.